C07D 417/02
Containing two hetero rings
Official title: containing two hetero rings
C07D417/02 (Containing two hetero rings) appears on 14,528 US grants and 15,891 published applications in this corpus.
Search patents in C07D- Granted patents
- 14,528
- Published applications
- 15,891
- Assignees
- 3,763
- Inventors
- 34,965
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 43 | 0 |
| 1977 | 44 | 0 |
| 1978 | 20 | 0 |
| 1979 | 11 | 0 |
| 1980 | 18 | 0 |
| 1981 | 16 | 0 |
| 1982 | 14 | 0 |
| 1983 | 31 | 0 |
| 1984 | 69 | 0 |
| 1985 | 92 | 0 |
| 1986 | 99 | 0 |
| 1987 | 130 | 0 |
| 1988 | 125 | 0 |
| 1989 | 152 | 0 |
| 1990 | 153 | 0 |
| 1991 | 169 | 0 |
| 1992 | 160 | 0 |
| 1993 | 209 | 0 |
| 1994 | 188 | 0 |
| 1995 | 182 | 0 |
| 1996 | 229 | 0 |
| 1997 | 283 | 0 |
| 1998 | 259 | 0 |
| 1999 | 255 | 0 |
| 2000 | 262 | 0 |
| 2001 | 276 | 62 |
| 2002 | 331 | 335 |
| 2003 | 320 | 515 |
| 2004 | 265 | 784 |
| 2005 | 292 | 709 |
| 2006 | 373 | 696 |
| 2007 | 405 | 712 |
| 2008 | 402 | 679 |
| 2009 | 464 | 802 |
| 2010 | 551 | 890 |
| 2011 | 507 | 778 |
| 2012 | 612 | 689 |
| 2013 | 678 | 679 |
| 2014 | 672 | 762 |
| 2015 | 674 | 732 |
| 2016 | 565 | 685 |
| 2017 | 579 | 589 |
| 2018 | 498 | 625 |
| 2019 | 491 | 602 |
| 2020 | 464 | 623 |
| 2021 | 393 | 491 |
| 2022 | 326 | 494 |
| 2023 | 317 | 643 |
| 2024 | 297 | 523 |
| 2025 | 338 | 446 |
| 2026 | 225 | 346 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
- C07D 417/12Linked by a chain containing hetero atoms as chain links8,463
- C07D 417/04Directly linked by a ring-member-to-ring-member bond4,378
- C07D 417/06Linked by a carbon chain containing only aliphatic carbon atoms2,646
- C07D 417/10Linked by a carbon chain containing aromatic rings1,157
- C07D 417/08Linked by a carbon chain containing alicyclic rings99
Recent patents
- Salt containing piperazine polycyclic derivative, crystal form thereof, preparation method therefor, and use thereof6 Oct 2026US 12,753,166 B2Jiangsu Hansoh Pharmaceutical Group Co., Ltd.
- 5-membered heteroarylaminosulfonamides for treating conditions mediated by deficient CFTR activity6 Oct 2026US 12,753,171 B2Genzyme Corporation
- Membrane-active anti-bacterial compounds and uses thereof29 Sep 2026US 12,747,213 B2Regents of the University of Minnesota
- Pyrazolyl compounds as KV7 channel activators29 Sep 2026US 12,747,237 B2
- Compounds for treatment of excitotoxicity29 Sep 2026US 12,747,238 B2Nyrada Pty Ltd
- Polymorphic forms and formulations of leriglitazone8 Oct 2026US 2026/0306468 A1Minoryx Therapeutics S.L.
- Mitochondrial uncouplers for treatment of metabolic diseases and cancer8 Oct 2026US 2026/0306502 A1Mito Biopharma, LLC
- Trpv4 receptor ligands8 Oct 2026US 2026/0308120 A1University of Utah Research Foundation
- Heterocyclic carboxylic acid hydrazide ligand and use thereof in copper-catalyzed aryl halide coupling reaction8 Oct 2026US 2026/0308125 A1Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences
- Crystal form of lanifibranor, preparation method therefor, and use thereof8 Oct 2026US 2026/0308150 A1Inventiva
Most cited
By later US patents
- Pyrrolidine-containing monomers and oligomers675US 5,519,134 AIsis Pharmaceuticals, Inc. · 1996
- Substituted unsymmetrical cyanine dyes with selected permeability384US 5,658,751 AMolecular Probes, Inc. · 1997
- Cyclic-substituted unsymmetrical cyanine dyes371US 5,436,134 AMolecular Probes, Inc. · 1995
- Chemically reactive unsymmetrical cyanine dyes and their conjugates289US 5,863,753 AMolecular Probes, Inc. · 1999
- Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof277US 5,549,974 AAffymax Technologies N.V. · 1996